Ghent, Belgium - 10 February 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of fluid overload in liver disease, heart failure ...
(1) The total number of outstanding shares of the Company mentioned in the relevant transparency notification amounts to 52,416,601, each share giving right to one (1) vote (being 52,416,601 ...
Kings defenceman worked hard to recover from pre-season ankle injury and was a late addition to Team Canada.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback